Coya Therapeutics, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Coya Therapeutics, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Less steady than 51% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Coya Therapeutics, Inc. made a loss over the last year. Coya Therapeutics, Inc. owes $0.09 for every $1 it owns. Coya Therapeutics, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossCoya Therapeutics, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.24The share price is 2.24 times Coya Therapeutics, Inc.'s book value per share, lower than 54% of Healthcare companies in United States.
Market cap
$97 MThe total market value of all of Coya Therapeutics, Inc.'s shares at today's price (share price × number of shares), smaller than 66% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$43 MWhat Coya Therapeutics, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.84Net worth divided by the number of shares. The share price of $4.14 is 2.2 times this, which is the P/B above.
Return on equity (ROE)
-60.5%Coya Therapeutics, Inc. lost 60.5% of its shareholders' money over the last year, lower than 58% of Healthcare companies in United States.
Owes vs Owns
0.09×Coya Therapeutics, Inc. owes $0.09 for every $1 it owns (low), lower than 89% of Healthcare companies in United States.
Dividend yield
NoneCoya Therapeutics, Inc. does not currently pay a dividend.
Revenue growth
+124%Revenue rose 124% in the year to Dec 2025.
Profit growth
LossCoya Therapeutics, Inc. made a loss in each of the last two years.
Profit margin
-267.1%Coya Therapeutics, Inc. lost $267 for every $100 of revenue.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Coya Therapeutics, Inc.: $97 M ÷ $43 M (30 Jun 2026) = 2.2.
What is Coya Therapeutics, Inc.'s return on equity?
Coya Therapeutics, Inc. lost 60.5% of its shareholders' money over the last year, lower than 58% of Healthcare companies in United States.
How much does Coya Therapeutics, Inc. owe compared with what it owns?
Coya Therapeutics, Inc. owes $0.09 for every $1 it owns (low), lower than 89% of Healthcare companies in United States.
Does Coya Therapeutics, Inc. pay a dividend?
No. Coya Therapeutics, Inc. does not currently pay a dividend.
Is Coya Therapeutics, Inc.'s revenue growing?
Revenue rose 124% in the year to Dec 2025.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.